CCM
QTTB icon

Consonance Capital Management’s Q32 Bio QTTB Stock Holding History

Consonance Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,253
Closed -$734K – 42
2019
Q3 		$734K Buy
2,253
+800
+55% +$272K 0.07% 28
2019
Q2 		$512K Buy
+1,453
New +$571K 0.04% 30

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Consonance Capital Management's QTTB Position: Q4 2019 in Review

Consonance Capital Management sold out of Q32 Bio (QTTB) in Q4 2019, closing a stake of 2,253 shares — an estimated $734K sold.

Consonance Capital Management first reported a position in QTTB in Q2 2019 and held it in 2 quarters. The position peaked at $734K in Q3 2019. 86 funds tracked by Wall St. Rank hold QTTB as of Q4 2019.

  • Consonance Capital Management reported no remaining Q32 Bio position as of Q4 2019 after selling out during the quarter.
  • Consonance Capital Management sold 2,253 Q32 Bio shares in Q4 2019, an estimated $734K.
  • Consonance Capital Management first reported a position in Q32 Bio in Q2 2019 and held it in 2 quarters.
  • Consonance Capital Management's Q32 Bio position peaked at $734K in Q3 2019.
  • 86 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2019.

Based on Consonance Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.